Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Lucena Research raises $1m in oversubscribed financing rounds

Wednesday, March 06, 2013
Opalesque Industry Update: Lucena Research, a provider of investment decision support technology to RIAs, small hedge funds and other sophisticated investors, announced that it has raised $1.025 million in two seed financing rounds. The investor list includes a hedge fund and a registered investment advisor that were instrumental in piloting Lucena’s QuantDesk software in late 2012. A group of angel investors also participated in the funding rounds including a senior executive who spent the past 20 years leading one of the world’s largest global wealth management service providers.

A pioneer in machine learning quantitative analysis, Lucena Research provides an innovative approach to price forecasting, portfolio optimization and hedging techniques. Derived from statistical forecasting, QuantDesk™ adapts to over 200 fundamental, technical, and proprietary time series indicators to help investment professionals with their ongoing investment decisions. QuantDesk™ is capable of constructing self-adjusted predictive models geared to exploit market opportunities and scientifically validate and support clients’ investment strategies and goals. Using Lucena’s pattern matching algorithms and portfolio replication methods, investment professionals can exploit market opportunities while also reducing risk in their portfolio.

“We are extremely pleased with the level of interest we were able to garner in such a short time. We are also thrilled with the level of professional pedigree we were able to attract as investors backing Lucena,” said CEO Erez Katz. “The high participation of industry experts who professionally specialize in wealth management is a testament to our unique value proposition and prospective growth. We are committed to deliver substantial value to our customers and consequently to our investors by providing powerful products and services geared to empower our clients with the latest advancements in machine learning and computational finance.”

Lucena Research

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for